Mechanistically, H19 expression is significant downregulated in the hearts of rats with diabetic cardiomyopathy, which leads to a reduced level of miR-675 and an increased level of miR-675 target-gene VDAC1. This evidence concerns the gene H19 and diabetic cardiomyopathy.